Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Capital Expenditures (2017 - 2025)

Inspire Medical Systems' Capital Expenditures history spans 9 years, with the latest figure at $10.7 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 51.64% year-over-year to $10.7 million; the TTM value through Dec 2025 reached $38.5 million, down 1.59%, while the annual FY2025 figure was $38.5 million, 1.59% down from the prior year.
  • Capital Expenditures for Q4 2025 was $10.7 million at Inspire Medical Systems, down from $22.1 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $28.2 million in Q3 2024 and bottomed at -$7.8 million in Q2 2024.
  • The 5-year median for Capital Expenditures is $1.5 million (2021), against an average of $5.5 million.
  • The largest YoY upside for Capital Expenditures was 3338.25% in 2024 against a maximum downside of 7850.5% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at -$383000.0 in 2021, then skyrocketed by 2127.15% to $7.8 million in 2022, then soared by 159.27% to $20.1 million in 2023, then tumbled by 65.09% to $7.0 million in 2024, then surged by 51.64% to $10.7 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Capital Expenditures are $10.7 million (Q4 2025), $22.1 million (Q3 2025), and -$2.6 million (Q2 2025).